Showing 3061-3070 of 4063 results for "".
- Compulink Showcases SMART Ophthalmology EHR Solution at Hawaiian Eye 2019https://modernod.com/news/compulink-showcases-smart-ophthalmology-ehr-solution-at-hawaiian-eye-2019/2476177/Compulink Healthcare Solutions will demonstrate its ophthalmology-specific system, Ophthalmology Advantage at Hawaiian Eye. Ophthalmology Advantage uses AI technology and real-time data from the clinic to completely automate tasks such as billing, along with eliminating steps to improve pa
- FDA Approved Record Number of Drugs in 2018https://modernod.com/news/fda-approved-record-number-of-drugs-in-2018/2476204/Last year was a banner year for the FDA, with 59 new drugs approved by the Center for Drug Evaluation and Research (CDER), including 19 first-in-class agents, 34 novel drugs for rare diseases, and a record seven biosimilars, according to a rep
- Healthe Named One of the Nation’s 20 Hottest Health Start-Upshttps://modernod.com/news/healthe-named-one-of-the-nations-20-hottest-health-start-ups/2476213/Healthe, an eye health company that develops products and technology to block ultra-violet and high-energy visible blue light, announced that it was selected by THE OBSERVER as one of the nation’s hottest digital health companies. The list focuses on non-coastal, start-ups from the Midwest, South
- George A. Williams, MD, Begins Term as 2019 President of the American Academy of Ophthalmologyhttps://modernod.com/news/george-a-williams-md-begins-term-as-2019-president-of-the-american-academy-of-ophthalmology/2476229/George A. Williams, MD, today begins his term as the 123rd president of the American Academy of Ophthalmology. Dr. Williams, a retina specialist, was elected by the Academy’s community of 32,000 ophthalmologists in recognition of his scientific leadership and his deep commitment to advocati
- Results RNA Issues Voluntary Worldwide Recall of Lubrisine Eye Drops Due to Manufacturing Sterility Concerns and Undeclared Colloidal Silverhttps://modernod.com/news/results-rna-issues-voluntary-worldwide-recall-of-lubrisine-eye-drops-due-to-manufacturing-sterility-concerns-and-undeclared-colloidal-silver/2476230/Results RNA is voluntarily recalling Lubrisine Eye Drops to the healthcare practitioner, retail or consumer level. This product, in a recent FDA inspection, was found to be manufactured using practices that do not support its sterility and contained undeclared colloidal silver.
- The Number of Optometric Practices Offering neurolens Contoured Prism Lenses More Than Quadrupled in 2018https://modernod.com/news/the-number-of-optometric-practices-offering-neurolens-contoured-prism-lenses-more-than-quadrupled-in-2018/2479617/Costa Mesa, California-based neurolens announced that adoption of their prescription lenses has grown among US optometric (OD) practices and by year end, 31 states will carry the company’s neurolenses and the neurolens measurement device. neurolenses are the first and only prescripti
- SECO International Partners With the American Society of Optometric Surgeons for SECO 2019https://modernod.com/news/seco-international-partners-with-the-american-society-of-optometric-surgeons-for-seco-2019/2479621/SECO International has announced that SECO, the educational conference providing ophthalmic professionals educational opportunities since 1924, has partnered with the American Society of Optometric Surgeons (ASOS) to bring hands-on demonstrations showing radiosurgical technology, Botox, and YAG l
- Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis Systemhttps://modernod.com/news/second-sight-announces-final-2019-medicare-hospital-outpatient-payment-rate-for-the-argus-ii-retinal-prosthesis-system/2479688/Second Sight Medical Products
- International Innovators in Medical and Surgical Eye Health to Convene in Chicago to Advance Patient Carehttps://modernod.com/news/international-innovators-in-medical-and-surgical-eye-health-to-convene-in-chicago-to-advance-patient-care/2479737/Thousands of eye physicians and surgeons this week will convene in Chicago to attend AAO 2018, the American Academy of Ophthalmology’s 122nd annual meeting. This gathering is an opportunity to hear global leaders in medical and surgical eye care discuss issues affecting patients’ lives, from the
- Optovue Highlights World’s First OCTA Metrics and Corneal Measurement Method at AAO 2018https://modernod.com/news/optovue-highlights-worlds-first-octa-metrics-and-corneal-measurement-method-at-aao-2018/2479742/Optovue will showcase AngioAnalytics, the world’s first OCTA blood vessel measurement technology to help physicians manage diseases that cause progressive blindness, and 3D PAR, its three-dimensional projection artifact removal software at the American Academy of Ophthalmology Annual Meeting (AAO